Protalix BioTherapeutics, Inc. (PLX) Insider Ownership

Historic Insider Ownership Trends

Data spanning the past 90 days through January 10, 2026 reveals that Protalix BioTherapeutics's three principal insider shareholders consist of TenPercentOwner Pharma Technologies Ltd. Dexcel (3.64Mn shares), President And Ceo Dror Bashan (2.53Mn shares), Sr. Vp And Cfo Eyal Rubin (660.91K shares).

Protalix BioTherapeutics, Inc. (PLX) exhibits a conventional ownership structure with institutions commanding 18.01% of outstanding shares, insider ownership remaining at 9.59%, and public/other investors holding 72.40%.
As of January 10, 2026, Protalix BioTherapeutics's insider ownership stands at 9.59% of outstanding equity, representing about 7.39Mn shares within the total 77.06Mn shares outstanding.
Throughout the 90-day span concluding January 10, 2026, Protalix BioTherapeutics's insider stake increased 7.83%, as collective insider positions growing from 6.86Mn shares to 7.39Mn shares.
Over the past 90 days through January 10, 2026, President And Ceo Dror Bashan demonstrated the strongest insider purchase conviction at Protalix BioTherapeutics, adding 56.00K shares to their position.
As of January 10, 2026, Director Amos Bar-Shalev executed the most significant insider divestiture at Protalix BioTherapeutics, disposing of 168 shares over the last 90-day period.

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.

Holder	Position	Shares	Report Date
Pharma Technologies Ltd. Dexcel		3,637,314	03 Jun, 2021
Dror Bashan	President And Ceo	2,532,934	23 Dec, 2025
Eyal Rubin	Sr. Vp And Cfo	660,909	05 Nov, 2024
Aharon Schwartz		310,500	12 Aug, 2025
Yaron Naos	Sr. Vp And Operations	225,817	04 Sep, 2025
Yael Hayon	Vp And Research & Development	35,115	17 Aug, 2023
Christian Elze		7,500	04 Sep, 2025
Pol F Boudes		7,500	04 Sep, 2025
Gwen A Melincoff		7,500	04 Sep, 2025
Eliot Forster		7,500	04 Sep, 2025
Zvi Shmuel Ben		7,500	04 Sep, 2025
Amos Bar-Shalev		7,500	19 Nov, 2025

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.

Rows:

Download Data

Transaction Date	Insider Name	Security Class	Transaction Type	Shares Traded	Price	Shares Remaining	Ownership	Code
19 Dec, 2025	Dror Bashan	Common Stock	A	56,000	$1.81	188,516	D	P
18 Nov, 2025	Amos Bar-Shalev	Common Stock	D	168	$1.87	0	D	S
03 Sep, 2025	Amos Bar-Shalev	Common Stock	A	7,500	-	7,500	I	A
03 Sep, 2025	Pol F Boudes	Common Stock	A	7,500	-	7,500	I	A
03 Sep, 2025	Gwen A Melincoff	Common Stock	A	7,500	-	7,500	I	A
03 Sep, 2025	Aharon Schwartz	Common Stock	A	7,500	-	7,500	I	A
03 Sep, 2025	Yaron Naos	Common Stock	A	25,000	-	225,817	I	A
03 Sep, 2025	Yaron Naos			-	-	225,817	I
03 Sep, 2025	Dror Bashan	Common Stock	A	195,000	-	2,344,418	I	A
03 Sep, 2025	Eliot Forster	Common Stock	A	7,500	-	7,500	I	A
03 Sep, 2025	Zvi Shmuel Ben	Common Stock	A	7,500	-	7,500	I	A
03 Sep, 2025	Christian Elze	Common Stock	A	7,500	-	7,500	I	A
10 Jun, 2025	Aharon Schwartz	Common Stock	A	129,000	$1.60	303,000	D	P
10 Jun, 2025	Aharon Schwartz			-	-	303,000	D
23 Sep, 2024	Eyal Rubin	Common Stock	A	99,010	-	669,010	I	A
23 Sep, 2024	Eyal Rubin			-	-	669,010	I
23 Sep, 2024	Eyal Rubin	Common Stock	A	90,909	-	660,909	I	A
19 Oct, 2023	Dror Bashan			-	-	132,516	D
19 Oct, 2023	Dror Bashan	Common Stock	A	16,129	$1.41	132,516	D	P
19 Oct, 2023	Dror Bashan			-	-	116,387	D

Showing 1 to 20 of 628 transactions

Research Tools

Protalix BioTherapeutics, Inc. (PLX) Insider Ownership

Historic Insider Ownership Trends

Top Direct Holders

Recent Insider Transactions

Create an account

Sign In

Reset Password

Get Pro for 60% off